Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience

Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.

Affiliations

¹ Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, New York.
² Department of Medicine, Weill Cornell Medicine, New York, New York.
³ The Rogosin Institute, New York, New York.

No abstract available

Keywords: COVID-19; CRRT; anticoagulation; continuous renal replacement therapy.

Publication types

Letter

MeSH terms

Acute Kidney Injury / therapy*
Acute Kidney Injury / virology
Aged
Anticoagulants / therapeutic use*
Arginine / analogs & derivatives
Arginine / therapeutic use
COVID-19 / complications*
Citric Acid / therapeutic use
Continuous Renal Replacement Therapy / instrumentation*
Disposable Equipment
Equipment Failure / statistics & numerical data*
Female
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Male
Middle Aged
Pipecolic Acids / therapeutic use
SARS-CoV-2
Sulfonamides / therapeutic use
Time Factors

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Pipecolic Acids
Sulfonamides
Citric Acid
Arginine
argatroban